Trial
NCT02072096
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
Glimepiride
Why stopped
The trial was terminated per protocol because of lack of feasibility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-09